STOCK-BASED COMPENSATION EXPENSE (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

Changes in restricted stock units, consisting primarily of annual automatic grants, deferred compensation to non-employee directors, and restricted stock units awards to the CEO, under the Incentive Compensation Plans during 2020 and 2019 are as follows:

	Restricted Stock Units	Grant Date Weighted- Average Fair Value		Intrinsic Value
Outstanding at January 1, 2019	4,000	$	2.68	$	—
Granted	36,000	$	2.50	$	—
Vested	(37,000)	$	2.47	$	—
Outstanding at December 31, 2019	3,000	$	3.03	$	—
Granted	144,000	$	1.96	$	—
Vested	(134,000)	$	1.98	$	—
Outstanding at December 31, 2020	13,000	$	1.97	$	2,000

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

As of December 31, 2020, stock compensation expense recorded in the consolidated financial statements is summarized as follows:

		Stock-Based
	Awards Issued	Compensation
Award Type	and Vested	Expense
Options	—	$	17,000
RSUs Issued in Lieu of Retainer Fees	—	80,000
Annual RSU Awards	3,000	7,000
Executive Compensation	100,000	195,000
Balance at of December 31, 2020	103,000	$	299,000

Share-based Compensation, Stock Options, Activity

Changes in stock options outstanding under the Incentive Compensation Plans during 2020 and 2019 are as follows:

Options	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Balance at December 31, 2018	613,000	$	2.85	3.14	$	—
Granted	18,000	$	2.87	7.00	$	—
Exercised	(16,000)	$	2.59	—	$	—
Forfeited	(165,000)	$	3.07	—	$	—
Balance at December 31, 2019	450,000	$	2.78	2.44	$	27,000
Granted	10,000	$	1.88	7.00	$	—
Forfeited	(43,000)	$	2.54	—	$	—
Balance at December 31, 2020	417,000	$	2.79	1.61	$	2,000
Exercisable at December 31, 2019	425,000	$	2.79	2.25	$	—
Exercisable at December 31, 2020	405,000	$	2.80	1.48	$	—

Schedule of Nonvested Share Activity

A summary of the status of the Company’s non-vested stock options as of December 31, 2020 and 2019, and changes during the years ended December 31, 2020 and 2019 is presented below:

Nonvested Options	Number of Options	Weighted Average Grant-Date Fair Value
Nonvested at December 31, 2018	125,000	$	1.20
Granted	18,000	$	1.54
Vested	(118,000)	$	1.22
Nonvested at December 31, 2019	25,000	$	1.40
Granted	10,000	$	0.78
Vested	(23,000)	$	1.22
Nonvested at December 31, 2020	12,000	$	1.07

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the Company’s option grants under the Plan in 2020 and 2019 was estimated using the following assumptions:

	2020		2019
Expected life (years)	7.0		7.0
Expected forfeiture rate	0.0	%	0.0	%
Expected volatility	40	%	50	%
Dividend yield	0	%	0	%
Risk-free interest rate	0.4	%	1.9	%